PART I Overview and Mission Myriad Genetics is a leading molecular diagnostics and precision medicine company committed to advancing health and well-being for all. We develop and commercialize molecular tests that help patients and providers uncover genetic insights. Our tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care, support earlier detection, enable more ...
Q2 FY2026 — expected 2026-08-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-24 | 2025-12-31 | 0000899923-26-000018 | EDGAR | 72K words |
| 2025-02-28 | 2024-12-31 | 0000899923-25-000019 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0000899923-24-000018 | EDGAR | — |
| 2023-03-01 | 2022-12-31 | 0000899923-23-000011 | EDGAR | — |
| 2022-02-25 | 2021-12-31 | 0000899923-22-000033 | EDGAR | — |
| 2020-08-13 | 2020-06-30 | 0001564590-20-040011 | EDGAR | — |
| 2019-08-13 | 2019-06-30 | 0001564590-19-031849 | EDGAR | — |
| 2018-08-24 | 2018-06-30 | 0001564590-18-022312 | EDGAR | — |
| 2017-08-09 | 2017-06-30 | 0001564590-17-017026 | EDGAR | — |
| 2016-08-10 | 2016-06-30 | 0001193125-16-677859 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-31 | 2026-06-30 | 0000899923-26-000072 | EDGAR | — |
| 2025-11-04 | 2025-09-30 | 0000899923-25-000112 | EDGAR | 20K words |
| 2025-08-06 | 2025-06-30 | 0000899923-25-000086 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0000899923-25-000048 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0000899923-24-000057 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0000899923-24-000041 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0000899923-24-000026 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0000899923-23-000087 | EDGAR | — |
| 2023-08-04 | 2023-06-30 | 0000899923-23-000058 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0000899923-23-000035 | EDGAR | — |
| 2022-11-02 | 2022-09-30 | 0000899923-22-000140 | EDGAR | — |
| 2022-08-05 | 2022-06-30 | 0000899923-22-000130 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-30 | 0000899923-26-000070 | EDGAR | — |
| 2026-02-23 | 0000899923-26-000012 | EDGAR | 9K words |
| 2026-01-12 | 0000899923-26-000003 | EDGAR | — |
| 2025-11-03 | 0000899923-25-000103 | EDGAR | — |
| 2025-10-07 | 0000899923-25-000096 | EDGAR | — |
| 2025-10-03 | 0000899923-25-000091 | EDGAR | — |
| 2025-08-18 | 0000899923-25-000089 | EDGAR | — |
| 2025-08-05 | 0000899923-25-000084 | EDGAR | — |
| 2025-07-31 | 0000899923-25-000072 | EDGAR | — |
| 2025-06-05 | 0000899923-25-000066 | EDGAR | — |
194 total filings indexed. 162 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000899923 |
| Ticker | MYGN |
| Exchange | Nasdaq |
| SIC | 2835: In Vitro & In Vivo Diagnostic Substances |
| Incorporated | DE |
| Website | https://www.myriad.com |
| Listed | 1995-10-06 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/MYGN (~200 tokens, structured JSON with cryptographic provenance)